Efficacy and safety of of SGLT2 ihibtors in post mi patients: a systematic review and meta-analysis of RCTs

Back

ESC Professional Premium Access

Efficacy and safety of of SGLT2 ihibtors in post mi patients: a systematic review and meta-analysis of RCTs

Session: Pharmacotherapy in coronary artery disease: from bench to bedside (1)

Topic: Pharmacotherapy

Speaker: Doctor M. Abouzid (Poznan, PL)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Mohamed Abouzid

Poznan University of Medical Sciences, Poznan (Poland)

1 follower

8 more presentations in this session

Platelet membrane coated r-SAK to improve thrombolytic efficacy by targeting thrombus

Speaker: Miss R. Hua (Nanjing, CN)

AtheroVax: a peptide vaccine with a therapeutic effect in animal model of chronic inflammation

Speaker: Professor E. Ramacciotti (Santo Andre, BR)

Sodium-glucose cotransporter 2 inhibitor attenuates left ventricular dysfunction in post-myocardial infarction in rats via reducing cardiac mitochondrial impairment

Speaker: Doctor C. Maneechote (Chiang Mai, TH)

A new free radical scavenger, resorcimoline, prevents ischaemia/reperfusion injury in the heart

Speaker: Doctor K. Ueno (Oita, JP)

Impact of dapagliflozin on cardiometabolic outcomes after myocardial infarction according to baseline glycaemic status and body mass index: a DAPA-MI substudy

Speaker: Professor R. Storey (Sheffield, GB)

Access the full session

Pharmacotherapy in coronary artery disease: from bench to bedside (1)

Speakers: Doctor M. Abouzid, Miss R. Hua, Professor E. Ramacciotti, Doctor C. Maneechote, Doctor K. Ueno...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources